Do you consume too many sugary drinks such as fruit juices, sports drinks, sodas, etc. Do you want to know if you are at higher risk for liver fat accumulation based on the amount of sugary drinks you consume? We are located in Kannapolis, approximately 30 minutes north of Charlotte.
We are looking for healthy volunteers to donate a one time blood sample to help us with our research. Your sample will be compared to subjects with end stage kidney disease on dialysis.
The CureGN Network acts as a "library" of data for investigators across the world to use to help us ask the following questions: 1) What is the disease?; 2) Why did it happen to me?; 3) Can it be passed down to my family members?; 4) What treatments work the best with the least side effects?
We have learned that there are differences in the cells of people with and without Lupus. By donating blood, you can help us learn why these differences happen, and whether we can target them to develop future treatments for lupus.
Current routine tests for patients with autoimmune diseases don';t always detect disease in all patients and poorly reflect how patient symptoms and treatment responses can vary. The development of tests to fine new autoimmune markers will help better personalize treatments strategies and may give doctors indicators to better track disease progression and therapy response. If you participate, we will ask for a one time donation of blood. Compensation provided.
Currently, there are no treatments approved by the regulatory agencies worldwide for patients with IgAN. By participating in this landmark Phase 3 study (sponsored by Calliditas), you will contribute to developing the first medication specifically targeting IgAN. In this trial you have a 50% chance of being treated with the investigational medication, Nefecon.
Do you have Type 2 diabetes and a history of cardiovascular disease, like a heart attack, stroke or chronic kidney disease? We are evaluating an oral medication to see if it helps lower the risk of future cardiovascluar events like these. Compensation provided.
If you have been treated with ANCA vasculitis and you are now in remission, you may be able to participate in a study to test if a specific blood test can help your doctor decide if you need maintenance therapy.
If you are between the ages of 18-49 and are actively listed on the transplant registry for a kidney transplant, you may be eligible to participate in this study looking at the effectiveness of the Gardasil-9 HPV Vaccine. You must not have previously had a transplant or received an HPV vaccine. Compensation is being provided for participation.
Have you been diagnosed with IgA Nephropathy and are you considering trying a new, experimental drug for treatment? Researchers want to learn more about the safety and effectiveness of VIS649 to treat IgAN.